Investment Plan: ¥1 trillion in cumulative capital investment over 5 years and ¥200 billion in R&D expenses in fiscal 2019
First written in FY2017. 14 of 16 entries say "Advanced", first in FY2018-Q2. Latest entry: FY2022.
4 other companies' latest entry also says "Advanced".
- FY2022AdvancedAnnual report
「Total capital investment during the current consolidated fiscal year was ¥189.389 billion, including investments in production facilities, R&D facilities and sales facilities. ... The capital investment plan for the one-year period following the current consolidated fiscal year totals ¥290 billion for the Company and its subsidiaries.」
Capital investment during the current fiscal year amounted to ¥189.389 billion, and a capital investment plan of ¥290 billion was presented for the following year. - FY2022-Q3AdvancedAnnual report
「Group-wide R&D expenses for the nine months ended the third quarter were ¥112.4 billion.」
R&D expenses for the nine-month cumulative period amounted to ¥112.4 billion in connection with growth investments under the new medium-term management plan. - FY2021-Q3AdvancedAnnual report
「Group-wide R&D expenses for the nine months ended the third quarter were ¥102.9 billion.」
In connection with the growth investment plan, R&D expenses for the nine months ended the third quarter amounted to ¥102.9 billion. No separate disclosure was made on overall progress against the capital investment plan. - FY2021-Q2AdvancedAnnual report
「The capital investment plan, which had been undetermined as of the end of the previous consolidated fiscal year in light of the impact of the spread of COVID-19, was determined as follows as of the end of the second quarter of the current consolidated fiscal year. The capital investment plan for the one-year current consolidated fiscal year totals ¥220 billion for the Company and its subsidiaries.」
The capital investment plan for the current consolidated fiscal year, which had been undetermined due to the impact of the spread of the infection, was set at ¥220 billion in total. The breakdown is ¥208 billion for the four-wheel vehicle business, ¥9 billion for the two-wheel vehicle business and ¥3 billion for the marine business and other operations. - FY2020SoftenedAnnual report
「The capital investment plan for the one-year period following the current consolidated fiscal year is currently being formulated in light of the impact of the spread of COVID-19 and has not yet been determined.」
Capital investment during the current fiscal year was ¥236.45 billion, but the capital investment plan for the following year has not yet been determined in light of the impact of the spread of the infection. - FY2020-Q3AdvancedAnnual report
「Group-wide R&D expenses for the nine months ended the third quarter were ¥105.6 billion.」
In connection with the growth investment plan, R&D expenses of ¥105.6 billion were recorded for the nine months ended the third quarter. - FY2020-Q2AdvancedAnnual report
「Group-wide R&D expenses for the six months ended the second quarter were ¥71.9 billion.」
In connection with the investment plan, including ¥200 billion in R&D spending for fiscal 2019, R&D expenses of ¥71.9 billion were recorded for the six months ended the second quarter. The overall progress against the plan was not stated. - FY2020-Q1AdvancedAnnual report
「The Group's R&D expenses for the three months ended the first quarter were ¥34.4 billion.」
In connection with the investment plan, including ¥200 billion in R&D spending for fiscal 2019, R&D expenses of ¥34.4 billion were recorded for the first quarter. The overall progress against the plan was not stated. - FY2019AdvancedAnnual report
「Capital expenditures during the current consolidated fiscal year reached a record high of ¥268.9 billion, and the company plans to maintain a high level of capital expenditures at ¥270.0 billion in the next consolidated fiscal year.」
Capital expenditures reached a record high of ¥268.9 billion, and ¥270.0 billion is planned for the following fiscal year. Growth investments, including capacity expansion in India and investment in new models, are continuing. - FY2019-Q3AdvancedAnnual report
「Cash flow from operating activities for the nine months ended the third quarter increased by ¥240.1 billion, despite a decrease in operating income, compared with an increase of ¥261.2 billion in the same period of the previous year. Cash of ¥208.0 billion was used in investing activities for the acquisition of property, plant and equipment, including investments to expand capacity in India, and the acquisition of securities, compared with a cash decrease of ¥191.3 billion in the same period of the previous year. As a result, free cash flow increased by ¥32.1 billion, compared with an increase of ¥69.9 billion in the same period of the previous year.」
The company used ¥208.0 billion in investing activities during the nine months ended the third quarter, including for the acquisition of property, plant and equipment and investments to expand capacity in India. Growth investments continued, but the disclosure does not state the achievement of the ¥1 trillion five-year cumulative capital expenditure target. - FY2019-Q2AdvancedAnnual report
「Cash flow from operating activities for the six months ended the second quarter increased by ¥224.1 billion due to business expansion, compared with an increase of ¥226.0 billion in the same period of the previous year. Cash of ¥160.3 billion was used in investing activities for the acquisition of property, plant and equipment, including investments to expand capacity in India, and the acquisition of securities, compared with a cash decrease of ¥134.7 billion in the same period of the previous year. As a result, free cash flow increased by ¥63.8 billion, compared with an increase of ¥91.3 billion in the same period of the previous year.」
The company used ¥160.3 billion in investing activities during the six months ended the second quarter, including for the acquisition of property, plant and equipment and investments to expand capacity in India. This indicates that growth investments were made, but does not state the achievement of the ¥1 trillion five-year cumulative capital expenditure target. - FY2019-Q1AdvancedAnnual report
「Cash flow from operating activities for the three months ended the first quarter increased by ¥106.1 billion due to business expansion, compared with an increase of ¥63.0 billion in the same period of the previous year. Cash of ¥113.2 billion was used in investing activities for the acquisition of property, plant and equipment, including investments to expand capacity in India, and the acquisition of securities, compared with a cash decrease of ¥44.6 billion in the same period of the previous year. As a result, free cash flow decreased by ¥7.1 billion, compared with an increase of ¥18.4 billion in the same period of the previous year.」
The company used ¥113.2 billion in investing activities during the quarter, including for the acquisition of property, plant and equipment and investments to expand capacity in India. This indicates the execution of investments related to the ¥1 trillion five-year cumulative capital expenditure plan, but does not state the cumulative achievement or progress rate for the plan. - FY2018AdvancedAnnual report
「Total capital expenditures during the current consolidated fiscal year were ¥213.376 billion, including investments in production facilities, R&D facilities, and sales facilities.」
In relation to the growth investment plan, capital expenditures during the year were ¥213.376 billion and R&D expenses were ¥139.4 billion. The disclosure does not indicate completion of the plan for ¥1 trillion in cumulative capital expenditures over 5 years and ¥200 billion in R&D expenses for fiscal 2019. - FY2018-Q3AdvancedAnnual report
「The Group's R&D expenses for the nine months ended the third quarter were ¥98.8 billion.」
In relation to the investment plan of ¥1 trillion in cumulative capital expenditures over 5 years and ¥200 billion in R&D expenses for fiscal 2019, the company disclosed R&D expenses of ¥98.8 billion for the nine months ended the third quarter. The disclosure does not itself indicate that the plan has been achieved. - FY2018-Q2AdvancedAnnual report
「The Group's R&D expenses for the six months ended the second quarter were ¥65.4 billion.」
In relation to the investment plan of ¥1 trillion in cumulative capital expenditures over 5 years and ¥200 billion in R&D expenses for fiscal 2019, the company disclosed R&D expenses of ¥65.4 billion for the six months ended the second quarter. The disclosure does not indicate that the plan has been achieved. - FY2017First statedAnnual report
「Under the New Medium-Term Management Plan (fiscal 2015–2019) SUZUKI NEXT 100, the Group plans to make aggressive growth investments, including ¥1 trillion in cumulative capital expenditures over 5 years and ¥200 billion in R&D expenses in fiscal 2019.」
The disclosure sets out the numerical growth investment plans of ¥1 trillion in cumulative capital expenditures for fiscal 2015–2019 and ¥200 billion in R&D expenses for fiscal 2019.